Can Pharma Marketing and R&D Profitably Coexist?

John LaMattina over at Forbes blog (here) is very concerned about the drug industry's current reputation, which has sunk to new lows since George W. Merck made this comment:"We try never to forget that medicine is for the people. It is not for the profits. The profits follow, and if we have remembered that, they have never failed to appear. The better we have remembered it, the larger they have been.""The culprits in this decline have been corporate types," says LaMattina, "particularly the sales and marketing folks (my emphasis), who are perceived as relentlessly driving to maximize profits at the expense of the welfare of patients."This view is not surprising considering that LaMattina was Pfizer's former President of R&D. What is surprising, however, is what LaMattina suggested a few sentences later in his post.Read more ยป
Source: Pharma Marketing Blog - Category: Pharma Commentators Tags: R & D Reputation Research Source Type: blogs